By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777



Company News
Prima Biomed (PRR.AX) To Host Conference Call & Webcast To Discuss Acquisition Of Immutep S.A. 10/22/2014 1:19:38 PM
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Australian Notice Of Allowance 10/14/2014 11:48:27 AM
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/3/2014 1:03:22 PM
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014 6:03:41 AM
Prima Biomed (PRR.AX) Release: CVac™ CAN-003 Abstract Accepted For Poster Presentation At The Society For Immunotherapy Of Cancer Annual Meeting 8/19/2014 10:10:16 AM
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014 10:26:01 AM
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014 8:11:13 AM
Prima Biomed (PRR.AX)'s CAN-002 CVac™ Trial Published In Journal For ImmunoTherapy Of Cancer 6/23/2014 8:15:45 AM
Prima Biomed (PRR.AX) To Present At WAGO Annual Meeting In California 6/19/2014 12:55:58 PM
Prima Biomed (PRR.AX) To Host Conference Call To Discuss Abstract Presented At American Society of Clinical Oncology On New Interim Overall Survival And Final Progression Free Survival Data For The Company's CAN-003 Trial 6/2/2014 10:50:00 AM